NASDAQ · Biotechnology

IOVA (IOVA) Stock

$4.36 +1.04% NASDAQ: IOVA Healthcare

Valuation

MetricValue
Price$4.36
Market Cap$1.95B
P/E Ratio-12.36
P/B Ratio2.40
P/S Ratio4.93
EPS (TTM)$-0.28
52-Week High$5.63
52-Week Low$1.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-47.51%
ROA-23.65%
ROCE-57.74%
Gross Margin1.15%
Operating Margin-1.27%
Net Margin-1.24%
Debt/Equity0.06
Current Ratio3.21

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$164.0M$264.0M
Operating Profit$-343.0M$-399.0M$-461.0M$-395.0M$-403.0M
Net Profit$-342.0M$-396.0M$-444.0M$-372.0M$-391.0M
EPS$-2.23$-2.49$-1.89$-1.28$-1.09
Op Margin——-38735.0%-240.9%-153.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$777.0M$664.0M$780.0M$910.0M$913.0M
Total Liabilities$156.0M$164.0M$196.0M$200.0M$215.0M
Cash$78.0M$232.0M$115.0M$116.0M$163.0M
Borrowings$72.0M$85.0M$76.0M$58.0M$48.0M

Latest News

Iovance Biotherapeutics (IOVA) Updates its Corporate Presentation, Here’s What’s Important to Note Insider Monkey · Jul 9, 2026 This Stock Is Up 74% This Year: Is It Too Late to Buy? Motley Fool · Jul 8, 2026 Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? Motley Fool · Jul 4, 2026 Iovance (IOVA) Surges 9.4% on Regulatory Nod Insider Monkey · Jun 24, 2026 Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? Motley Fool · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-228.0M$-293.0M$-362.0M$-353.0M$-302.0M
Investing Cash Flow$-37.0M$236.0M$-178.0M$-107.0M$14.0M
Financing Cash Flow$35.0M$1.0M$0$-7.0M$-7.0M
Net Cash Flow$11.0M$154.0M$-57.0M$-59.0M$47.0M
Free Cash Flow$-266.0M$-313.0M$-384.0M$-364.0M$-336.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.84
FCF Yield-21.65%
Quick Ratio3.15
Interest Coverage—
Return 1Y30.60%
Return 3Y-29.65%
Return 5Y-77.51%

Ownership

Insiders Held0.34%
Institutions Held67.72%
Institutions Float Held67.95%
Institutional HolderSharesReport Date
Blackrock Inc.31,080,5052026-03-31
MHR Fund Management, LLC28,967,1032026-03-31
State Street Corporation17,448,1082026-03-31
Vanguard Capital Management LLC16,617,7372026-03-31
Two Sigma Investments, LP13,687,4332026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATXSAstria Therapeutics, Inc. $12.58 +0.00% -7.40 $718.13M 0.00%
AVBP $30.84 -0.55% -8.82 $1.44B 0.00%
CTMX $3.37 +4.01% -24.27 $541.98M 0.00%
DNA $8.07 -0.19% -1.30 $527.50M 0.00%
ERAS $17.72 -2.42% -23.45 $6.15B 0.00%

About IOVA

IOVA is led by CEO Frederick G. Vogt, publicly traded since 2010.

IOVA stock trades at $4.36 with a market capitalization of $1.95B. The stock is valued at a price-to-earnings (P/E) ratio of -12.36, price-to-book of 2.40, price-to-sales of 4.93. Over the past 52 weeks the stock has ranged between $1.66 and $5.63, and currently trades 22.6% below its 52-week high.

On profitability, IOVA generates a return on equity (ROE) of -47.51%, return on capital employed of -57.74%, an operating margin of -1.27%, a net profit margin of -1.24%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides